Department of Otolaryngology-Head and Neck Surgery.
Department of Radiation Oncology, Vanderbilt University Medical Center.
Otol Neurotol. 2021 Feb 1;42(2):e209-e215. doi: 10.1097/MAO.0000000000002893.
1: Describe subacute facial nerve paralysis after salvage stereotactic radiosurgery (SRS). 2: To analyze predictors of facial nerve weakness after dual modality treatment.
Adult patients with Vestibular Schwannoma who underwent sub-total resection (STR) followed by salvage radiation.
Microsurgical resection of VS, stereotactic radiosurgery, intensity-modulated radiotherapy, proton radiotherapy.
Serial facial nerve function (House-Brackmann scale).
Thirteen patients who underwent dual modality treatment for large VS were included (mean age = 43.6 years, 77% females). The mean pre-operative tumor volume was 11.7 cm3 (SD = 6.5) and the immediate mean post-operative remnant volume was 1.5 cm3 (SD = 1.4) with a mean extent of resection of 86.7% (SD = 9.5). The mean salvage-free interval was 20.8 months (SD = 13.3). All patients had excellent one-year FN outcome (HB grade 1, 2) after resection. Three patients developed subacute facial nerve weakness after salvage SRS (4.2-9.4 months after SRS). This paralysis responded to high dose systemic steroids and no surgical interventions for facial rehabilitation were required. At last follow up (mean 61.6 months, SD = 28.5), facial nerve function was favorable (HB grade 1-2 in 12 patients and HB grade 3 in 1 patient). There were no significant associations between various predictors and subacute deterioration of facial nerve function after SRS.
Sub-acute transient facial nerve dysfunction can develop infrequently over a variable time frame after post-operative salvage SRS and usually responds to steroids. Patients should be adequately counseled about potential of transient deterioration of facial nerve function after salvage SRS.
接受次全切除术(STR)后行挽救性放疗的成人听神经鞘瘤患者。
VS 的显微切除术、立体定向放射外科、调强放疗、质子放疗。
面神经功能的连续评估(House-Brackmann 量表)。
共纳入 13 例接受双模式治疗大型听神经鞘瘤的患者(平均年龄 43.6 岁,女性占 77%)。术前肿瘤平均体积为 11.7cm3(SD=6.5),术后即刻残余肿瘤平均体积为 1.5cm3(SD=1.4),平均切除程度为 86.7%(SD=9.5)。挽救性无进展间隔时间平均为 20.8 个月(SD=13.3)。所有患者在切除术后 1 年面神经功能均良好(HB 分级 1、2)。3 例患者在挽救性 SRS 后出现亚急性面神经无力(SRS 后 4.2-9.4 个月)。这种麻痹对大剂量全身类固醇治疗有反应,不需要手术干预进行面神经康复。末次随访(平均 61.6 个月,SD=28.5)时,面神经功能良好(12 例患者为 HB 分级 1-2,1 例患者为 HB 分级 3)。在 SRS 后面神经功能亚急性恶化与各种预测因素之间无显著相关性。
手术后挽救性 SRS 后可能会在不同的时间范围内出现亚急性短暂性面神经功能障碍,通常对类固醇治疗有反应。应充分告知患者 SRS 后面神经功能暂时恶化的潜在风险。